BioAge Historical Balance Sheet
| BIOA Stock | 18.80 0.49 2.54% |
Trend analysis of BioAge Labs, balance sheet accounts such as Short Long Term Debt Total of 28.9 M, Other Current Liabilities of 5.4 M or Total Current Liabilities of 30 M provides information on BioAge Labs,'s total assets, liabilities, and equity, which is the actual value of BioAge Labs, to its prevalent stockholders. By breaking down trends over time using BioAge Labs, balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining BioAge Labs, latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BioAge Labs, is a good buy for the upcoming year.
BioAge Labs, Inventory |
|
BioAge |
About BioAge Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of BioAge Labs, at a specified time, usually calculated after every quarter, six months, or one year. BioAge Labs, Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of BioAge Labs, and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which BioAge currently owns. An asset can also be divided into two categories, current and non-current.
BioAge Labs, Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of BioAge Labs, assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in BioAge Labs, books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Most accounts from BioAge Labs,'s balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into BioAge Labs, current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.At present, BioAge Labs,'s Net Debt is projected to increase significantly based on the last few years of reporting. The current year's Cash is expected to grow to about 24.2 M, whereas Total Assets are forecasted to decline to about 24.6 M.
| 2017 | 2018 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 37.6M | 2.5M | 53.3M | 28.9M | Total Assets | 69.5M | 28.4M | 25.9M | 24.6M |
BioAge Labs, balance sheet Correlations
Click cells to compare fundamentals
BioAge Labs, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether BioAge Labs, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioAge Labs,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioage Labs, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioage Labs, Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs,. If investors know BioAge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAge Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.40) |
The market value of BioAge Labs, is measured differently than its book value, which is the value of BioAge that is recorded on the company's balance sheet. Investors also form their own opinion of BioAge Labs,'s value that differs from its market value or its book value, called intrinsic value, which is BioAge Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAge Labs,'s market value can be influenced by many factors that don't directly affect BioAge Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAge Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAge Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAge Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.